Global Amniocentesis Needle Market - Segmented by Type, Procedure, End User, and Geography - Growth, Trends, and Forecast (2022 - 2030)
The global amniocentesis needle market is expected to register a CAGR of about 5.4% over the forecast period, 2018-2023. Amniocentesis is a procedure that is used for the diagnosis of fetal defects in the second trimester of pregnancy. A sample from the amniotic fluid, surrounding the fetus in the womb, is collected through a pregnant woman's abdomen using a needle and syringe.
High Reliability of Amniocentesis
Amniocentesis is ~ 99.4% accurate. This test determines if the baby in the womb has any genetic or chromosomal abnormalities. The test can identify many genetic disorders, such as Down syndrome, Edward’s syndrome, Tay-Sachs disease, Huntington’s disease, Sickle cell disease, and cystic fibrosis. Other testing techniques, like ultrasounds, pick up on the genetic defects or problems that might be there in the fetus. However, only amniocentesis can provide the information needed to diagnosis these complications in the fetus. Due to the high reliability of the test, this market is expected to expand during the forecast period. Other factors, such as, the growth in the median age of first-time motherhood and heavy burden of congenital disorders are also expected to drive the market studied.
Availability of Alternate Methods
Amniocentesis is an invasive procedure where a needle in inserted into the womb of the mother for the collection of amniotic fluid, in order to study the possibility of prenatal disorders. Although Amniocentesis is a fairly safe procedure, there are occasional cases where it may lead to miscarriages, as the procedure involves invasive methods. Due to this, many pregnant women prefer the usage of alternative testing options, such as noninvasive prenatal test (NIPT), first trimester combined screening, second trimester quad screen, and integrated screening, among others. This is expected to slow down the growth of the amniocentesis needle market.
North America to Maintain Lead in the Market
The global amniocentesis needle market is dominated by North America and Europe respectively. North America will continue to dominate the global market during the forecast period. Factors, such as the rising government initiatives and increasing healthcare expenditure, are driving the growth of the market in this region.
Key Developments:
• March 2018 - A team of researchers led by Brock A. Peters, PhD, of Complete Genomics in San Jose, California, have shown that amniocentesis linked with whole-genome sequencing (WGS) can be used to analyze a fetus' entire genome for harmful mutations. Peters' team collected amniotic fluid from 31 pregnant women and isolated DNA from both the amniotic fluid and the fetal cells within it.
Major Players: BECTON, DICKINSON AND COMPANY, BIOPSYBELL, COOK MEDICAL, COOPERSURGICAL, INTEGRA LIFESCIENCES, LABORATOIRE CCD, MEDLINE, MEDTRONIC, SMITHS MEDICAL, and TSUNAMI MEDICAL, amongst others.
Reasons to Purchase the Report
• Current and future amniocentesis needle market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
High Reliability of Amniocentesis
Amniocentesis is ~ 99.4% accurate. This test determines if the baby in the womb has any genetic or chromosomal abnormalities. The test can identify many genetic disorders, such as Down syndrome, Edward’s syndrome, Tay-Sachs disease, Huntington’s disease, Sickle cell disease, and cystic fibrosis. Other testing techniques, like ultrasounds, pick up on the genetic defects or problems that might be there in the fetus. However, only amniocentesis can provide the information needed to diagnosis these complications in the fetus. Due to the high reliability of the test, this market is expected to expand during the forecast period. Other factors, such as, the growth in the median age of first-time motherhood and heavy burden of congenital disorders are also expected to drive the market studied.
Availability of Alternate Methods
Amniocentesis is an invasive procedure where a needle in inserted into the womb of the mother for the collection of amniotic fluid, in order to study the possibility of prenatal disorders. Although Amniocentesis is a fairly safe procedure, there are occasional cases where it may lead to miscarriages, as the procedure involves invasive methods. Due to this, many pregnant women prefer the usage of alternative testing options, such as noninvasive prenatal test (NIPT), first trimester combined screening, second trimester quad screen, and integrated screening, among others. This is expected to slow down the growth of the amniocentesis needle market.
North America to Maintain Lead in the Market
The global amniocentesis needle market is dominated by North America and Europe respectively. North America will continue to dominate the global market during the forecast period. Factors, such as the rising government initiatives and increasing healthcare expenditure, are driving the growth of the market in this region.
Key Developments:
• March 2018 - A team of researchers led by Brock A. Peters, PhD, of Complete Genomics in San Jose, California, have shown that amniocentesis linked with whole-genome sequencing (WGS) can be used to analyze a fetus' entire genome for harmful mutations. Peters' team collected amniotic fluid from 31 pregnant women and isolated DNA from both the amniotic fluid and the fetal cells within it.
Major Players: BECTON, DICKINSON AND COMPANY, BIOPSYBELL, COOK MEDICAL, COOPERSURGICAL, INTEGRA LIFESCIENCES, LABORATOIRE CCD, MEDLINE, MEDTRONIC, SMITHS MEDICAL, and TSUNAMI MEDICAL, amongst others.
Reasons to Purchase the Report
• Current and future amniocentesis needle market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
